Click Here to Receive your 100 Unit Sample Kit
GOOD NEWS! ProMedicus USA has partnered with MSMA to allow MSMA members to receive a new, innovative, HIPAA Compliant, FDA Registered Class II healthcare screening test -
MY SAFE PASS™
The MY SAFE PASS™ (MSP) Olfactory Scent Test was designed to pre-screen and rapidly identify (60 second) early warning symptoms for many underlying diseases including Parkinson’s Disease, Alzheimer’s Disease, and other neurological disorders.
MY SAFE PASS™ (MSP) Olfactory Scent Test is a highly accurate, rapid (60 second), affordable, safe and non-invasive, MADE IN USA, test used to screen patients for major medical conditions, including symptoms of neurodegenerative disorders, such as Alzheimer's and Parkinson’s, Concussions, and viral infections such as COVID-19 at the earliest stages. The test can be easily administered, by either the patient or staff at check-in, using a validated scent protocol accessible through standard electronic devices.
MY SAFE PASS™ is offering 100 free sample kits (valued at $2000.00), to qualified providers, through its distributor, ProMedicus USA (www.promedicususa.com). The low cost of $5.00 or less per test, with suggested billing at $20.00, provides an additional $15.00 income per patient for office management's cost coverage. A one-time, refundable/deductible $150.00 administrative fee is required to set up your office in the IOS system. MSP can provide real-time HIPAA-compliant patient test results to your office, allowing for accurate billing and patient record updates. (Can be billed more specifically using CPT92700 Billing Code R.43. Olfactory Test - Smell & Taste Disorders).
Decades of clinical peer-reviewed, published research shows that scent accuracy and scent disorders are the first, earliest, and sometimes the only symptom of neurodegenerative disorders, such as Alzheimer's and Parkinson's, hyposmia (a decreased sense of smell or decreased ability of scent accuracy), viral infections, such as COVID-19, as well as mild to moderate concussions and Traumatic Brain Injury (TBI).
The test uses a clinically tested and validated scent protocol accessible through standard electronic devices. The low cost and potential to identify patients with neurodegenerative disorders, viral infections, and concussions make it an ideal screening tool along with your routine temperature, blood pressure, oxygen intake and other diagnostic information gathered from patients upon check-in.
To access more information on this exciting new screening tool, please review the links provided or visit our ProMedicus USA website - www.promedicususa.com.
Click Here to Receive your 100 Unit Sample Kit
My Safe Pass Product Information
Order More